NewsRx

Search our medical news database

ID Biomedical Corporation

Biotechnology company enters Fluviral vaccine marketing, distribution agreements

Published in Health Business Week, January 7th, 2005

ID Biomedical Corporation (IDBE) has signed long-term marketing, distribution, and minimum purchase agreements with Henry Schein, Inc., AmerisourceBergen Corporation's Specialty Group, and McKesson Corporation.

Under the terms of the agreements, each of the distributors has agreed to purchase a minimum number of doses of Fluviral vaccine from ID Biomedical beginning upon U.S. Food and Drug Administration (FDA) clearance. The purchases could begin as early as next year, and will end after the 2014/2015 flu season.

It is the expectation of the parties that ID Biomedical's Fluviral will be licensed in the U.S. by at least the 2007/08 influenza season,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook